CAMBRIDGE, Mass., May 26 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated will webcast its presentations at Sanford Bernstein’s 22nd Annual Strategic Decisions Conference and the Bear Biotech Boston Confab.
Joshua Boger, Ph.D., President and Chief Executive Officer of Vertex, will present at the Sanford Bernstein Strategic Decisions Conference on Wednesday, May 31, 2006 at 8:00 a.m. EDT.
Ian Smith, Executive Vice President and Chief Financial Officer, and John Alam, M.D., Executive Vice President, Medicines Development and Chief Medical Officer at Vertex, will present at the Bear Biotech Boston Confab. The presentation and discussion will also be conducted on Wednesday, May 31, 2006 and will take place at 5:40 p.m. EDT.
The presentations will be webcast live and may be accessed by visiting the Vertex website at http://www.vrtx.com. A replay of the webcasts will also be available on the Company’s website for two weeks following the presentations. To access the webcasts, go to Vertex’s website and select the ‘Sanford Bernstein 22nd Annual Strategic Decisions Conference’ or the ‘Bear Biotech Boston Confab’ from the ‘Events Calendar.’ To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast.
About Vertex
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company’s strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex’s product pipeline is principally focused on viral diseases, inflammation, autoimmune diseases and cancer. In collaboration with GlaxoSmithKline, Vertex co-promotes the HIV protease inhibitor, Lexiva.
Lexiva is a registered trademark of the GlaxoSmithKline group of companies.
Vertex’s press releases are available at http://www.vrtx.com. Vertex Contact: Lora Pike, Manager, Investor Relations, (617) 444-6755
Vertex Pharmaceuticals Incorporated
CONTACT: Lora Pike, Manager, Investor Relations of Vertex PharmaceuticalsIncorporated, +1-617-444-6755
Web site: http://www.vrtx.com//
Company News On-Call: http://www.prnewswire.com/comp/938395.html/
